Trinity Biotech (TRIB) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

TRIB Trinity Biotech

Watchlist

1.7200
-0.2800-14.00%

Close Oct 14 16:00 ET

1.7000
-0.0200-1.16%

Post 19:06 ET

16.28MMarket Cap-623P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

European Equities Traded in the US as American Depositary Receipts Ends Week Higher in Friday Trading
MT NewswiresOct 11 11:13 ET
Trinity Biotech PLC (TRIB) Q2 2024 Earnings Call Highlights: Strong Point-of-Care Growth Amidst ...
Yahoo FinanceOct 9 18:23 ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
BenzingaOct 8 08:08 ET
Trinity Biotech Reports Positive Pre-pivotal Study Data For Continuous Glucose Monitor Technology
RTTNewsOct 7 09:01 ET
Express News | Trinity Biotech PLC - Second European Pre-Pivotal Trial Scheduled for Q4 2024
ReutersOct 7 08:15 ET
Express News | Trinity Biotech PLC - Refined Sensor Achieves Favourable Mard Compared to Previous Device
ReutersOct 7 08:15 ET

Comments

Zack5225

Oct 11 09:30

$Trinity Biotech (TRIB.US)$ 3

Rocket589xrp

Oct 9 07:03

$Trinity Biotech (TRIB.US)$ some movement

Trytosaveabit

Oct 7 07:19

Update

$Trinity Biotech (TRIB.US)$ Reuters· 3 mins ago
Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology

Jaguar8

Oct 7 07:17

NEWS

$Trinity Biotech (TRIB.US)$
Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology
DUBLIN, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the successful completion of its first pre-pivotal clinical trial in Europe for its next-generation continuous glucos...